APA

Keravis T., Monneaux F., Yougbaré I., Gazi L., Bourguignon J., Muller S. & Lugnier C. (20120514). Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor. : PloS one.

Chicago

Keravis Thérèse, Monneaux Fanny, Yougbaré Issaka, Gazi Lucien, Bourguignon Jean-Jacques, Muller Sylviane and Lugnier Claire. 20120514. Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor. : PloS one.

Harvard

Keravis T., Monneaux F., Yougbaré I., Gazi L., Bourguignon J., Muller S. and Lugnier C. (20120514). Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor. : PloS one.

MLA

Keravis Thérèse, Monneaux Fanny, Yougbaré Issaka, Gazi Lucien, Bourguignon Jean-Jacques, Muller Sylviane and Lugnier Claire. Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor. : PloS one. 20120514.